Dose escalation study of proton therapy after spacer implantation for unresectable locally advanced pancreatic body tail cancer

Dose Escalation Study of Proton Therapy in Combination with Absorbable Spacer Implantation for Unresectable Locally Advanced Pancreatic Body Tail Cancer - Dose Escalation Study of Proton Therapy in Combination with Absorbable Spacer Implantation for Unresectable Locally Advanced Pancreatic Body Tail Cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051400

Enrollment

Registered

2023-07-01

Start date

2023-06-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unresectable locally advanced pancreatic body/tail cancer

Interventions

Proton therapy dose escalation study (up to 82.5 Gy/25 fractions) after absorbable spacer implantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. pathologycally diagnosed pancretatic cancer 2. ECOG PS 1-2 3. Informed consent

Exclusion criteria

Exclusion criteria: 1. Distant metastasis

Design outcomes

Primary

Measure	Time frame
Efficacy and safety	—

Countries

Japan

Contacts

Public ContactKazuki Terashima

Hyogo Ion Beam Medical Center Department of Radiology

terashima@kmyr.jp0791-58-0100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026